CRISPR

CRISPR1-dhx38

ID
ZDB-CRISPR-240827-1
Name
CRISPR1-dhx38
Previous Names
None
Target
Sequence
5' - GCCTTCTAGCCGGTGCAGGG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
hzu20 dhx38
zf4116 dhx38
zko2862A dhx38
zko2862B dhx38
Expression
Gene expression in Wild Types + CRISPR1-dhx38
No data available
Phenotype
Phenotype resulting from CRISPR1-dhx38
No data available
Phenotype of all Fish created by or utilizing CRISPR1-dhx38
Phenotype Fish Conditions Figures
whole organism cdkn1a expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 3 with image from Ren et al., 2024
whole organism dead, abnormal dhx38hzu20/hzu20 standard conditions Fig. 8 with image from Tu et al., 2022
trunk mdm2 expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 8 with image from Tu et al., 2022
trunk smc5 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
trunk septin6 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
trunk aaas expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
trunk knl1 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
trunk scrib expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
whole organism bcl2a expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 3 with image from Ren et al., 2024
inner ear smc5 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 5 with image from Ren et al., 2024
whole organism col11a2 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 6 with image from Ren et al., 2024
trunk cenpk expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
neutrophilic myelocyte mpeg1.2 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 1 with image from Tu et al., 2022
otolith otomp expression decreased distribution, abnormal dhx38hzu20/hzu20 standard conditions Figure 2 with image from Ren et al., 2024
trunk mis18a expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
trunk cep131 expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
otolith stm expression decreased distribution, abnormal dhx38hzu20/hzu20 standard conditions Figure 2 with image from Ren et al., 2024
inner ear foxm1 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 5 with image from Ren et al., 2024
otolith stm expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 2 with image from Ren et al., 2024
trunk ccng2 expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
common myeloid progenitor gata1a expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 1 with image from Tu et al., 2022
whole organism pax2a expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 6 with image from Ren et al., 2024
inner ear apoptotic process increased occurrence, abnormal dhx38hzu20/hzu20 standard conditions Figure 3 with image from Ren et al., 2024
whole organism tp53 expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 3 with image from Ren et al., 2024
inner ear fanci expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 5 with image from Ren et al., 2024
macula utricle cahz expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 2 with image from Ren et al., 2024
otic vesicle decreased size, abnormal dhx38hzu20/hzu20 standard conditions Figure 1 with image,  Figure 3 with image from Ren et al., 2024
trunk eme1 expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
neutrophilic myelocyte spi1b expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 1 with image from Tu et al., 2022
trunk pard3ab expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
neutrophilic myelocyte cebpa expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 1 with image from Tu et al., 2022
otolith otomp expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 2 with image from Ren et al., 2024
whole organism casp8 expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 3 with image from Ren et al., 2024
trunk mdm4 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 8 with image from Tu et al., 2022
inner ear slx4 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 5 with image from Ren et al., 2024
otic vesicle protrusion absent, ameliorated dhx38hzu20/hzu20 chemical treatment by environment: p53 inhibitor Figure 3 with image from Ren et al., 2024
whole organism gadd45ba expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 3 with image from Ren et al., 2024
whole organism ret expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 6 with image from Ren et al., 2024
inner ear rad9a expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 5 with image from Ren et al., 2024
intrinsic apoptotic signaling pathway by p53 class mediator increased occurrence, abnormal dhx38hzu20/hzu20 standard conditions Fig. 8 with image from Tu et al., 2022
trunk cdkn1a expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 8 with image from Tu et al., 2022
intermediate cell mass of mesoderm gata1a expression amount, ameliorated dhx38hzu20/hzu20 chemical treatment by environment: p53 inhibitor Fig. 8 with image from Tu et al., 2022
otic vesicle protrusion absent, abnormal dhx38hzu20/hzu20 standard conditions Figure 1 with image,  Figure 3 with image from Ren et al., 2024
inner ear mRNA splicing, via endonucleolytic cleavage and ligation disrupted, abnormal dhx38hzu20/hzu20 standard conditions Figure 5 with image,  Figure 6 with image from Ren et al., 2024
trunk rad9a expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
whole organism viability, ameliorated dhx38hzu20/hzu20 chemical treatment by environment: p53 inhibitor Fig. 8 with image from Tu et al., 2022
trunk tonsl expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
trunk recql expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
semicircular canal ncs1a expression absent, abnormal dhx38hzu20/hzu20 standard conditions Figure 2 with image from Ren et al., 2024
inner ear ints7 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 5 with image from Ren et al., 2024
trunk eme1 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
trunk trip12 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
common myeloid progenitor lmo2 expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 1 with image from Tu et al., 2022
whole organism baxa expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 3 with image from Ren et al., 2024
erythroblast hbae1.1 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 1 with image from Tu et al., 2022
semicircular canal dacha expression absent, abnormal dhx38hzu20/hzu20 standard conditions Figure 2 with image from Ren et al., 2024
inner ear development disrupted, abnormal dhx38hzu20/hzu20 standard conditions Figure 1 with image,  Figure 2 with image from Ren et al., 2024
trunk rad9a expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
whole organism bbc3 expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 3 with image from Ren et al., 2024
inner ear eme1 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 5 with image from Ren et al., 2024
trunk aaas expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
intermediate cell mass of mesoderm myb expression amount, ameliorated dhx38hzu20/hzu20 chemical treatment by environment: p53 inhibitor Fig. 8 with image from Tu et al., 2022
trunk double-strand break repair decreased process quality, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
granulocyte decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 2 with image from Tu et al., 2022
trunk cell cycle process decreased process quality, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
trunk dtl expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
trunk chromosome segregation decreased process quality, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
trunk trip12 expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
whole organism cep290 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 6 with image from Ren et al., 2024
neutrophilic myelocyte mpx expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 1 with image from Tu et al., 2022
trunk tonsl expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
whole organism smad5 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 6 with image from Ren et al., 2024
semicircular canal bmp4 expression absent, abnormal dhx38hzu20/hzu20 standard conditions Figure 2 with image from Ren et al., 2024
trunk kdm8 expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
trunk smc5 expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
trunk dtl expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
trunk ccnb2 expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
trunk knl1 expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
trunk bbc3 expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 8 with image from Tu et al., 2022
trunk kdm8 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
trunk septin6 expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
trunk scrib expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
trunk mak expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
whole organism masp1 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 6 with image from Ren et al., 2024
whole organism spns2 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 6 with image from Ren et al., 2024
inner ear apoptotic process increased occurrence, ameliorated dhx38hzu20/hzu20 chemical treatment by environment: p53 inhibitor Figure 3 with image from Ren et al., 2024
trunk ccnb2 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
intermediate cell mass of mesoderm myb expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 8 with image from Tu et al., 2022
trunk cenpk expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
inner ear nuclear chromosome damaged, abnormal dhx38hzu20/hzu20 standard conditions Figure 4 with image from Ren et al., 2024
trunk ccng2 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
trunk lzts2a expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
intermediate cell mass of mesoderm gata1a expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 8 with image from Tu et al., 2022
inner ear rad17 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 5 with image from Ren et al., 2024
inner ear tonsl expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 5 with image from Ren et al., 2024
blood island macrophage decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 2 with image from Tu et al., 2022
trunk ift20 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image from Tu et al., 2022
inner ear foxj1b expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 2 with image from Ren et al., 2024
trunk mak expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
trunk recql expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
trunk mis18a expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
trunk lzts2a expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
trunk cep131 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
inner ear blm expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 5 with image from Ren et al., 2024
neutrophilic myelocyte mfap4.1 expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 1 with image from Tu et al., 2022
saccule cahz expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 2 with image from Ren et al., 2024
trunk tp53 expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 8 with image from Tu et al., 2022
otolith decreased size, abnormal dhx38hzu20/hzu20 standard conditions Figure 1 with image from Ren et al., 2024
otic vesicle size, ameliorated dhx38hzu20/hzu20 chemical treatment by environment: p53 inhibitor Figure 3 with image from Ren et al., 2024
whole organism mdm2 expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 3 with image from Ren et al., 2024
trunk pard3ab expression spatial pattern, abnormal dhx38hzu20/hzu20 standard conditions Fig. 7 with image from Tu et al., 2022
trunk microtubule cytoskeleton organization decreased process quality, abnormal dhx38hzu20/hzu20 standard conditions Fig. 6 with image,  Fig. 7 with image from Tu et al., 2022
inner ear mms22l expression decreased amount, abnormal dhx38hzu20/hzu20 standard conditions Figure 5 with image from Ren et al., 2024
intermediate cell mass of mesoderm tp53 expression increased amount, abnormal dhx38hzu20/hzu20 standard conditions Fig. 8 with image from Tu et al., 2022
macrophage EGFP expression decreased amount, abnormal dhx38hzu20/hzu20; ihb20Tg/ihb20Tg standard conditions Fig. 2 with image from Tu et al., 2022
neutrophilic myelocyte EGFP expression increased amount, abnormal dhx38hzu20/hzu20; zf4117Tg/zf4117Tg standard conditions Fig. 2 with image from Tu et al., 2022
caudal hematopoietic tissue hematopoietic multipotent progenitor cell EGFP expression increased amount, abnormal dhx38hzu20/hzu20; is5Tg/is5Tg; zf169Tg/zf169Tg standard conditions Fig. 3 with image from Tu et al., 2022
hematopoietic multipotent progenitor cell mitotic spindle DsRed expression spatial pattern, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 5 with image from Tu et al., 2022
caudal hematopoietic tissue EGFP expression decreased amount, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 8 with image from Tu et al., 2022
common myeloid progenitor mitotic spindle DsRed expression spatial pattern, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 5 with image from Tu et al., 2022
caudal hematopoietic tissue EGFP expression amount, ameliorated dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg chemical treatment by environment: p53 inhibitor Fig. 8 with image from Tu et al., 2022
caudal hematopoietic tissue blood cell DsRed expression amount, ameliorated dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg chemical treatment by environment: p53 inhibitor Fig. 8 with image from Tu et al., 2022
hematopoietic multipotent progenitor cell mitotic spindle Ab21-tuba labeling spatial pattern, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 5 with image from Tu et al., 2022
hematopoietic multipotent progenitor cell regulation of cell cycle phase transition decreased process quality, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 4 with image from Tu et al., 2022
caudal hematopoietic tissue hematopoietic multipotent progenitor cell DsRed expression increased amount, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 3 with image from Tu et al., 2022
common myeloid progenitor EGFP expression increased amount, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 2 with image,  Fig. 4 with image from Tu et al., 2022
common myeloid progenitor mitotic chromosome condensation decreased process quality, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 5 with image from Tu et al., 2022
hematopoietic multipotent progenitor cell mitotic spindle EGFP expression spatial pattern, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 5 with image from Tu et al., 2022
common myeloid progenitor mitotic spindle Ab21-tuba labeling spatial pattern, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 5 with image from Tu et al., 2022
common myeloid progenitor regulation of cell cycle phase transition decreased process quality, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 4 with image from Tu et al., 2022
caudal hematopoietic tissue hematopoietic multipotent progenitor cell EGFP expression increased amount, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 3 with image from Tu et al., 2022
common myeloid progenitor mitotic spindle EGFP expression spatial pattern, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 5 with image from Tu et al., 2022
caudal hematopoietic tissue programmed cell death increased occurrence, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 4 with image from Tu et al., 2022
caudal hematopoietic tissue hematopoietic stem cell differentiation decreased occurrence, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 3 with image from Tu et al., 2022
caudal hematopoietic tissue myeloid cell differentiation premature, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 3 with image from Tu et al., 2022
caudal hematopoietic tissue hematopoietic stem cell differentiation premature, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 3 with image from Tu et al., 2022
caudal hematopoietic tissue hematopoietic multipotent progenitor cell DsRed expression decreased amount, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 3 with image from Tu et al., 2022
caudal hematopoietic tissue hematopoietic multipotent progenitor cell EGFP expression decreased amount, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 3 with image from Tu et al., 2022
hematopoietic multipotent progenitor cell mitotic chromosome condensation decreased process quality, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 5 with image from Tu et al., 2022
common myeloid progenitor DsRed expression increased amount, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 2 with image,  Fig. 4 with image from Tu et al., 2022
caudal hematopoietic tissue blood cell DsRed expression decreased amount, abnormal dhx38hzu20/hzu20; sd2Tg/sd2Tg; zf169Tg/zf169Tg standard conditions Fig. 8 with image from Tu et al., 2022
Citations